KRT17 and triple-negative breast carcinoma: The positive expression rate of KRT17 was 82% (28/34) in the triple-negative breast cancer cells, The positive expression rate of KRT17 was 46% (52/112) in non-triple-negative breast cancer cells and 0 (0/15) in lobular carcinoma.